glp 1 farmacos NUEVOS FÁRMACOS EN DIABETES MELLITUS This product is not intended to diagnose GLP-1 y GIP: Las hormonas

6 It also complicates attribution: in a person taking both drugs, an observed gastric-emptying delay cannot be cleanly credited to cagrilintide

[73] [74] Over two years of follow-up, tirzepatide decreased participants' risk of major cardiovascular (CV) complicationsa combined endpoint including urgent heart failure visits, hospitalizations, more frequent diuretic treatment, and CV mortalityby 38% compared to a placebo

Zenobi PD, Glatz Y, Keller A, Graf S, Jaeggi-Groisman SE, Riesen WF, Schoenle EJ, Froesch ER

75.4%) compared to the DPP-4i group, although these differences were below the minimum SMD threshold of 0.2